Top Health-care stocks:
Health care shares were mostly lower at session's half Thursday.
In health care stocks news, Bristol-Myers Squibb ( BMY ) was down 2% after reporting Q2 adjusted EPS of $0.69, three cents above street view as compiled by Capital IQ, and up from $0.53 reported a year earlier. The company posted Q2 revenues of $4.87 billion, above the street consensus of $4.66 billion, and above the $4.16 billion reported a year earlier. In guidance, Bristol-Myers said it is "increasing its non-GAAP EPS guidance range (for full-year 2016) from $2.50 to $2.60 to $2.55 to $2.65."
And, Acorda Therapeutics ( ACOR ) was down 6.9% after the company reported non-GAAP earnings of $0.07 per share, down from $0.31 a year ago and missing the $0.24 average estimate compiled by Capital IQ by a large margin. Revenue rose to $127.5 million from $113.7 million, but nevertheless were shy of the $129.8 million consensus.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.